HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julio Pascual Selected Research

almotriptan (Axert)

1/2019Almotriptan: a review of 20 years' clinical experience.
10/2010Almotriptan: a review of 10 years' clinical experience.
10/2007Use of almotriptan in triptan-experienced and triptan-naïve patients.
2/2006Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example.
1/2005Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
1/2003Almotriptan: an effective and well-tolerated treatment for migraine pain.
2/2002How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
1/2002Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better.
1/2002Clinical benefits of early triptan therapy for migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julio Pascual Research Topics

Disease

47Migraine Disorders (Migraine)
06/2022 - 01/2002
18Headache (Headaches)
06/2022 - 01/2002
18Infections
07/2021 - 01/2009
16Hypertension (High Blood Pressure)
07/2020 - 07/2006
14Chronic Renal Insufficiency
01/2022 - 10/2007
14Proteinuria
01/2021 - 07/2006
13COVID-19
12/2022 - 07/2020
13Pain (Aches)
04/2017 - 01/2002
12Neoplasms (Cancer)
01/2021 - 07/2006
10Diabetic Nephropathies (Diabetic Nephropathy)
03/2022 - 09/2008
8Diabetes Mellitus
01/2021 - 07/2006
8Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 12/2006
7Obesity
01/2022 - 09/2014
6Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 01/2008
6Kidney Diseases (Kidney Disease)
05/2021 - 05/2018
5Frailty
01/2022 - 01/2021
5Fibrosis (Cirrhosis)
12/2021 - 06/2014
5Renal Insufficiency (Renal Failure)
01/2021 - 11/2003
5Epilepsy (Aura)
01/2019 - 01/2002
5Primary Headache Disorders
10/2014 - 03/2004
4Delayed Graft Function
10/2022 - 01/2008
4Albuminuria
01/2022 - 01/2014
4Brain Death (Brain Dead)
11/2021 - 09/2008
4Inflammation (Inflammations)
05/2021 - 12/2013
4Atherosclerosis
10/2019 - 01/2010
4Virus Diseases (Viral Diseases)
10/2019 - 06/2003
3Body Weight (Weight, Body)
01/2022 - 12/2006
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 05/2005
3Acute Kidney Injury (Acute Renal Failure)
01/2018 - 02/2013
3Autosomal Dominant Polycystic Kidney (ADPKD)
01/2017 - 09/2014
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2016 - 10/2007
3Cluster Headache (Cluster Headaches)
10/2013 - 07/2003
2Diarrhea
12/2022 - 01/2019
2Morbid Obesity
01/2022 - 05/2020
2Cytomegalovirus Infections (Inclusion Disease)
10/2021 - 01/2017
2Secondary Hyperparathyroidism
07/2021 - 01/2018
2Reperfusion Injury
03/2021 - 12/2013
2Chronic Disease (Chronic Diseases)
02/2021 - 03/2018
2Disease Progression
02/2021 - 01/2017
2Urinary Tract Infections (Urinary Tract Infection)
02/2021 - 01/2020
2Hematologic Diseases (Blood Diseases)
04/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2012
14Tryptamines (Triptans)IBA
01/2019 - 01/2002
12CreatinineIBA
12/2021 - 07/2006
9almotriptan (Axert)FDA Link
01/2019 - 01/2002
8AntibodiesIBA
01/2022 - 06/2003
8SteroidsIBA
01/2021 - 07/2006
8EverolimusFDA Link
10/2019 - 05/2005
7Pharmaceutical PreparationsIBA
07/2021 - 01/2003
5Calcitonin Gene-Related PeptideIBA
12/2022 - 10/2013
5Antiviral Agents (Antivirals)IBA
09/2021 - 12/2016
5Calcineurin InhibitorsIBA
01/2016 - 07/2006
5Indomethacin (Indometacin)FDA LinkGeneric
10/2014 - 03/2004
5Pain-FreeIBA
10/2013 - 01/2002
4VaccinesIBA
01/2022 - 09/2011
4AlbuminsIBA
12/2021 - 06/2014
4Vitamin DFDA LinkGeneric
07/2021 - 01/2012
4Insulin (Novolin)FDA Link
01/2021 - 01/2014
4Spironolactone (Aldactone)FDA LinkGeneric
07/2020 - 01/2016
4EnzymesIBA
01/2020 - 09/2005
4Type A Botulinum Toxins (Botox)FDA Link
12/2017 - 04/2012
4Analgesics (Analgesic Drugs)IBA
10/2016 - 10/2005
4Angiotensin-Converting Enzyme 2IBA
10/2016 - 01/2013
4rizatriptan (Maxalt)FDA Link
12/2013 - 02/2002
4Sirolimus (Rapamycin)FDA Link
05/2007 - 05/2005
4Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2006 - 11/2004
3galcanezumabIBA
06/2022 - 11/2021
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2013
3CytokinesIBA
01/2022 - 12/2013
3thymoglobulinFDA Link
11/2021 - 04/2014
3erenumabIBA
10/2021 - 04/2016
3paricalcitol (Zemplar)FDA Link
07/2021 - 03/2016
3MineralsIBA
07/2021 - 01/2020
3Rituximab (Mabthera)FDA Link
01/2021 - 03/2010
3NeuropeptidesIBA
01/2021 - 01/2017
3MTOR InhibitorsIBA
10/2020 - 12/2016
3Immunosuppressive Agents (Immunosuppressants)IBA
05/2019 - 07/2006
3Antihypertensive Agents (Antihypertensives)IBA
01/2016 - 01/2009
3Angiotensin IIIBA
01/2015 - 06/2014
3Proteins (Proteins, Gene)FDA Link
01/2014 - 06/2003
3Topiramate (Topamax)FDA LinkGeneric
04/2012 - 07/2003
3CholesterolIBA
01/2009 - 07/2006
2Messenger RNA (mRNA)IBA
01/2022 - 01/2022
2Calcitriol (Calcijex)FDA LinkGeneric
07/2021 - 03/2006
2Complement System Proteins (Complement)IBA
04/2021 - 01/2018
2FosfomycinFDA Link
02/2021 - 01/2020
2Immunoglobulin G (IgG)IBA
01/2021 - 07/2010
2Glutens (Glutelin)IBA
01/2021 - 01/2021
2Calcifediol (Calcidiol)FDA Link
01/2021 - 01/2018
2Diphosphonates (Bisphosphonates)IBA
01/2021 - 01/2020
2tocilizumab (atlizumab)FDA Link
11/2020 - 11/2020
2Phosphates (Orthophosphate)IBA
08/2020 - 10/2019

Therapy/Procedure

30Kidney Transplantation
01/2022 - 11/2003
23Therapeutics
11/2021 - 01/2002
20Transplantation
10/2022 - 12/2006
10Renal Dialysis (Hemodialysis)
07/2021 - 01/2008
4Bariatric Surgery
01/2022 - 05/2020
3Aftercare (After-Treatment)
10/2021 - 10/2008
3Renal Replacement Therapy (Therapies, Renal Replacement)
05/2021 - 09/2014
3Denervation
01/2018 - 01/2016